Oliver von Stein

Chief Executive Officer at Berlin Cures Holding AG

Health Technology

Commercial Services

Consumer Services

Profile

Oliver von Stein was the founder and had founded InDex Pharmaceuticals Holding AB in 2000, where he held the title of Chief Scientific Officer from 2009 to 2013.
He is currently the Chief Executive Officer at Berlin Cures Holding AG since 2023.
Dr. von Stein's former positions include Operations Director at Silence Therapeutics Plc from 2014 to 2015 and Project Leader at MediGene AG.
Dr. von Stein holds a doctorate degree from Karlsruher Institut für Technologie.

Oliver von Stein active positions

Companies	Position	Start
Berlin Cures Holding AG Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023.	Chief Executive Officer	15/06/2023

All active positions of Oliver von Stein

Former positions of Oliver von Stein

Companies	Position	End
SILENCE THERAPEUTICS PLC	Chief Operating Officer	01/08/2015
MEDIGENE AG	Corporate Officer/Principal	-
INDEX PHARMACEUTICALS HOLDING AB	Founder	-

See the detail of Oliver von Stein's experience

Training of Oliver von Stein

Karlsruher Institut für Technologie

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Oliver von Stein's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
INDEX PHARMACEUTICALS HOLDING AB	Health Technology
MEDIGENE AG	Health Technology
SILENCE THERAPEUTICS PLC	Commercial Services

Private companies	1
Berlin Cures Holding AG Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023.	Health Technology